These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 17462782)
1. Serum adiponectin is increased in advancing liver fibrosis and declines with reduction in fibrosis in chronic hepatitis B. Hui CK; Zhang HY; Lee NP; Chan W; Yueng YH; Leung KW; Lu L; Leung N; Lo CM; Fan ST; Luk JM; Xu A; Lam KS; Kwong YL; Lau GK; J Hepatol; 2007 Aug; 47(2):191-202. PubMed ID: 17462782 [TBL] [Abstract][Full Text] [Related]
2. Serum adipokine levels in chronic liver diseases: association of resistin levels with fibrosis severity. Tsochatzis E; Papatheodoridis GV; Hadziyannis E; Georgiou A; Kafiri G; Tiniakos DG; Manesis EK; Archimandritis AJ Scand J Gastroenterol; 2008; 43(9):1128-36. PubMed ID: 18609175 [TBL] [Abstract][Full Text] [Related]
3. Serum hyaluronic acid and laminin as biomarkers in liver fibrosis. Parsian H; Rahimipour A; Nouri M; Somi MH; Qujeq D; Fard MK; Agcheli K J Gastrointestin Liver Dis; 2010 Jun; 19(2):169-74. PubMed ID: 20593050 [TBL] [Abstract][Full Text] [Related]
4. Effect of antiviral therapy on the immunohistochemical expression of bcl-xL and bax protein in patients with HBeAg-negative chronic hepatitis B. Cholongitas E; Papatheodoridis GV; Manesis EK; Petraki K; Tiniakos D; Hadziyannis SJ J Med Virol; 2011 Jul; 83(7):1165-71. PubMed ID: 21567420 [TBL] [Abstract][Full Text] [Related]
5. Changes in liver histology as a "surrogate" end point of antiviral therapy for chronic HBV can predict progression to liver complications. Hui CK; Leung N; Shek WH; Zhang HY; Luk JM; Poon RT; Lo CM; Fan ST; Lau GK; J Clin Gastroenterol; 2008; 42(5):533-8. PubMed ID: 18344885 [TBL] [Abstract][Full Text] [Related]
6. Comparative assessment of liver fibrosis by computerized morphometry in naïve patients with chronic hepatitis B and C. Sturm N; Marlu A; Arvers P; Zarski JP; Leroy V Liver Int; 2013 Mar; 33(3):428-38. PubMed ID: 23402612 [TBL] [Abstract][Full Text] [Related]
7. Adiponectin changes in HCV-Genotype 4: relation to liver histology and response to treatment. Derbala M; Rizk N; Al-Kaabi S; Amer A; Shebl F; Al Marri A; Aigha I; Alyaesi D; Mohamed H; Aman H; Basem N J Viral Hepat; 2009 Oct; 16(10):689-96. PubMed ID: 19486470 [TBL] [Abstract][Full Text] [Related]
8. Fibrosis is associated with adiponectin resistance in chronic hepatitis C virus infection. Corbetta S; Redaelli A; Pozzi M; Bovo G; Ratti L; Redaelli E; Pellegrini C; Beck-Peccoz P; Spada A Eur J Clin Invest; 2011 Aug; 41(8):898-905. PubMed ID: 21539538 [TBL] [Abstract][Full Text] [Related]
9. On-treatment monitoring of liver fibrosis with transient elastography in chronic hepatitis B patients. Wong GL; Wong VW; Choi PC; Chan AW; Chim AM; Yiu KK; Chu SH; Chan FK; Sung JJ; Chan HL Antivir Ther; 2011; 16(2):165-72. PubMed ID: 21447865 [TBL] [Abstract][Full Text] [Related]
10. Prevalence of hepatic steatosis in chronic hepatitis B patients and its association with disease severity. Lesmana LA; Lesmana CR; Pakasi LS; Krisnuhoni E Acta Med Indones; 2012 Jan; 44(1):35-9. PubMed ID: 22451183 [TBL] [Abstract][Full Text] [Related]
11. [Expression of interleukin-17 in hepatitis B related liver fibrosis]. Xu Y; DU WJ; Qin LY; Xing ZZ; Qin XH; Chen SJ Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Feb; 25(2):133-5. PubMed ID: 19174010 [TBL] [Abstract][Full Text] [Related]
12. Correlation of liver stiffness and histological features in healthy persons and in patients with occult hepatitis B, chronic active hepatitis B, or hepatitis B cirrhosis. Fung J; Lai CL; Chan SC; But D; Seto WK; Cheng C; Wong DK; Lo CM; Fan ST; Yuen MF Am J Gastroenterol; 2010 May; 105(5):1116-22. PubMed ID: 19920809 [TBL] [Abstract][Full Text] [Related]
13. Increased interleukin-32 expression in chronic hepatitis B virus-infected liver. Xu Q; Pan X; Shu X; Cao H; Li X; Zhang K; Lu J; Zou Y; Li X; Liu H; Zhang Y; Yang D; Ning Q; Shen G; Li G J Infect; 2012 Oct; 65(4):336-42. PubMed ID: 22687868 [TBL] [Abstract][Full Text] [Related]
14. Lamivudine for patients with chronic hepatitis B and advanced liver disease. Liaw YF; Sung JJ; Chow WC; Farrell G; Lee CZ; Yuen H; Tanwandee T; Tao QM; Shue K; Keene ON; Dixon JS; Gray DF; Sabbat J; N Engl J Med; 2004 Oct; 351(15):1521-31. PubMed ID: 15470215 [TBL] [Abstract][Full Text] [Related]
15. Histological improvement of long-term antiviral therapy in chronic hepatitis B patients with persistently normal alanine aminotransferase levels. Du X; Wang J; Shao L; Hu X; Yang C; Shen L; Weng X; Zhang W J Viral Hepat; 2013 May; 20(5):328-35. PubMed ID: 23565615 [TBL] [Abstract][Full Text] [Related]
16. [The value of serum retinol-binding protein 4 levels for determining disease severity in patients with chronic liver disease]. Kwon JH; Park ST; Kim GD; You CR; Kim JD; Woo HY; Jang JW; Kim CW; Bae SH; Choi JY; Yoon SK Korean J Hepatol; 2009 Mar; 15(1):59-69. PubMed ID: 19346786 [TBL] [Abstract][Full Text] [Related]
17. Noninvasive models to predict liver cirrhosis in patients with chronic hepatitis B. Kim BK; Kim SA; Park YN; Cheong JY; Kim HS; Park JY; Cho SW; Han KH; Chon CY; Moon YM; Ahn SH Liver Int; 2007 Sep; 27(7):969-76. PubMed ID: 17696936 [TBL] [Abstract][Full Text] [Related]
18. Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis. Gaia S; Carenzi S; Barilli AL; Bugianesi E; Smedile A; Brunello F; Marzano A; Rizzetto M J Hepatol; 2011 Jan; 54(1):64-71. PubMed ID: 20932598 [TBL] [Abstract][Full Text] [Related]
19. Hepatic steatosis and fibrosis in young men with treatment-naïve chronic hepatitis B. Yun JW; Cho YK; Park JH; Kim HJ; Park DI; Sohn CI; Jeon WK; Kim BI; Son BH; Shin JH Liver Int; 2009 Jul; 29(6):878-83. PubMed ID: 19192167 [TBL] [Abstract][Full Text] [Related]
20. Adiponectin: a new independent predictor of liver steatosis and response to IFN-alpha treatment in chronic hepatitis C. Zografos TA; Liaskos C; Rigopoulou EI; Togousidis E; Makaritsis K; Germenis A; Dalekos GN Am J Gastroenterol; 2008 Mar; 103(3):605-14. PubMed ID: 18190648 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]